Research and development of therapeutic effectors targeting β1,4-galactosyltransferase7 (Q3697467): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: translated_label) |
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
||
| Property / beneficiary | |||
| Property / beneficiary: Q2536134 / rank | |||
Normal rank | |||
Revision as of 17:16, 24 November 2021
Project Q3697467 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Research and development of therapeutic effectors targeting β1,4-galactosyltransferase7 |
Project Q3697467 in France |
Statements
12,000.0 Euro
0 references
24,000.0 Euro
0 references
50.0 percent
0 references
1 January 2015
0 references
31 December 2016
0 references
Université de Lorraine
0 references
Le projet vise à concevoir, développer et cribler des molécules à visée régénératrice et thérapeutique ciblant spécifiquement la β4GalT7 (French)
0 references
The project aims to design, develop and screen regenerative and therapeutic molecules specifically targeting β4GalT7 (English)
22 November 2021
0 references
Identifiers
LO0006448
0 references